Search
for
Sort by
Research 901–930 of 1000+
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Neuroimmunology of Stress: Skin Takes Center Stage
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Dermatoses of pregnancy
- Vitamin D and the skin: Focus on a complex relationship: A review
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Mood and Sexual Function in Polycystic Ovary Syndrome
- The cycling hair follicle as an ideal systems biology research model
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Emotion Dysregulation of Women with Premenstrual Syndrome
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Clinical and histopathologic features of hair loss in patients with HIV-1 infection
- Evidence-based approach to cutaneous hyperandrogenism in women
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- The Clinical Presentation of Systemic Lupus Erythematosus
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Novel agents for the treatment of alopecia
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Post-finasteride syndrome: An emerging clinical problem
- Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases?